All In MedTech

Company

Rxsight

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.

Public

Listed

RXST

Nasdaq · RxSight, Inc.

Public float

$504M

Value of shares held by non-insiders on Jun 30, 2025

Revenue

$134M

Fiscal year ending Dec 31, 2025

Net income

-$38.9M

Fiscal year ending Dec 31, 2025

R&D spending

$38.5M

Fiscal year ending Dec 31, 2025

Cash

$66.7M

As of Sep 30, 2026

Long-term debt

Not reported

Shares outstanding

41.9M

As of Oct 30, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2025–$4.0M––
2024$108M$20.8M––
2023$54.0M$9.5M––
2022–$1.8M––
2021$120M$12.4M––

Private placements (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Feb 24, 2017Equity$50.0M$77.5M62Rule 506(b)Form D/A ↗Apr 3, 20171 amendment

Company details

From the company's latest Form D.

Legal name
RxSight, Inc.
Headquarters
Aliso Viejo, California
Incorporated
California over five years before filing
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

    9 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    The investor database is part of the paid tier

    For Rxsight we have 4 shareholders with 5% or more.

    It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

    Latest FDA decisions

    Search the Clearance Tracker

    4 more FDA decisions with a free account

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar

    6 more trials with a free account

    Reports received

    561

    Received Nov 1, 2025 to Nov 19, 2026. Includes 1 of another or unstated type.

    Malfunction reports

    32

    5.7% of reports

    Injury reports

    528

    94% of reports

    Death reports

    0

    0.0% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 2301100
    Jan 240900
    Feb 2402000
    Mar 2412000
    Apr 2411600
    May 2402100
    Jun 2401800
    Jul 2411300
    Aug 2402500
    Sep 2432100
    Oct 2412200
    Nov 2403900
    Dec 2433600
    Jan 2521700
    Feb 2503300
    Mar 2532100
    Apr 2512600
    May 2523900
    Jun 2515000
    Jul 2534500
    Aug 2515800
    Sep 2534000
    Oct 2504300
    Nov 2513200
    Dec 2544300
    Jan 2613400
    Feb 2635000
    Mar 2626400
    Apr 2635800
    May 2643800
    Jun 2655900
    Jul 2644201
    Aug 2613100
    Sep 2623500
    Oct 2624200
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    1 more in this ranking with a free account

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    7 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    No recalls under this name in FDA's data.

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.